[Primary and secondary failure of sulphonylureas].
作者信息
Kanno Hiroko, Sakura Hiroshi
机构信息
Diabetes Center, Tokyo Women's Medical University.
出版信息
Nihon Rinsho. 2002 Oct;60 Suppl 10:719-23.
PMID:12430308
Abstract
摘要
相似文献
1
[Primary and secondary failure of sulphonylureas].
Nihon Rinsho. 2002 Oct;60 Suppl 10:719-23.
2
Mechanism of action of sulphonylureas with special reference to the extrapancreatic effect: an overview.磺酰脲类药物的作用机制，特别涉及胰腺外效应：综述。
Diabet Med. 1988 Oct;5(7):613-20. doi: 10.1111/j.1464-5491.1988.tb01068.x.
3
Glibenclamide, a new sulphonylurea: whither oral hypoglycaemic agents?格列本脲，一种新型磺酰脲类药物：口服降糖药何去何从？
Drugs. 1971;1(2):109-15. doi: 10.2165/00003495-197101020-00001.
4
Cardiovascular effects of sulphonylureas: role of K(ATP) channels.磺脲类药物的心血管效应：K(ATP)通道的作用
Diabetes Obes Metab. 2000 Apr;2(2):67-73. doi: 10.1046/j.1463-1326.2000.00047.x.
5
[Current concepts of the pancreatic and extrapancreatic mechanisms of the action of peroral hypoglycemic sulfonylurea preparations].[口服降糖磺脲类制剂作用的胰腺及胰腺外机制的当前概念]
Probl Endokrinol (Mosk). 1985 Mar-Apr;31(2):76-85.
6
[Clinical efficacy of glimepiride].格列美脲的临床疗效
Nihon Rinsho. 1997 Nov;55 Suppl:152-7.
7
[Differential therapy using oral antidiabetics].[使用口服抗糖尿病药物的差异疗法]
Internist (Berl). 1971 Nov;12(11):468-75.
8
The pathogenesis of non-insulin-dependent diabetes: an update.非胰岛素依赖型糖尿病的发病机制：最新进展
Medicine (Baltimore). 1982 May;61(3):125-40. doi: 10.1097/00005792-198205000-00001.
9
Role of sulfonylureas in non-insulin-dependent diabetes mellitus: Part I--"The pros".
Horm Metab Res. 1996 Sep;28(9):517-21. doi: 10.1055/s-2007-979844.
10
[Structure and action mechanism of sulfonylurea].[磺酰脲类的结构与作用机制]
Nihon Rinsho. 2002 Sep;60 Suppl 9:333-8.
Zotero 插件